Regaal Resources reports FY26 PAT of ₹55.6 crore, commissions expansion
Regaal Resources Limited reported a 23.9% year-on-year increase in operating income to ₹1,134.2 crores for FY26, with a PAT of ₹55.6 crores. The company commissioned a significant expansion on May 26, 2026, raising crushing capacity to 1,650 TPD and adding liquid glucose and maltodextrin facilities. The Board recommended a dividend of ₹0.25 per share.

*this image is generated using AI for illustrative purposes only.
Regaal Resources Limited reported an operating income of ₹1,134.2 crores for the financial year ended March 31, 2026, with a Profit After Tax (PAT) of ₹55.6 crores and a margin of 4.9%. The company's Board has recommended a dividend of ₹0.25 per share, subject to shareholder approval. This performance was accompanied by the commissioning of a significant manufacturing expansion on May 26, 2026, scaling crushing capacity to 1,650 tons per day (TPD).
Financial Performance
For the full year FY26, operating income grew by 23.9% year-on-year to ₹1,134.2 crores. Value-added products increased by 18% to ₹295.8 crores. Operating EBITDA stood at ₹126.6 crores with a margin of 11.2%, while PAT was ₹55.6 crores. In Q4 FY26, operating income was ₹244.6 crores, with an operating EBITDA of ₹32.5 crores and a PAT of ₹16.5 crores.
| Metric | FY26 Value |
|---|---|
| Operating Income | ₹1,134.2 crores |
| Operating EBITDA | ₹126.6 crores |
| PAT | ₹55.6 crores |
| Net Debt-Equity Ratio | 1.1x |
| Cash Conversion Cycle | 50 days |
Expansion and Capacity
The company successfully commissioned an expansion on May 26, 2026, increasing its crushing capacity to 1,650 TPD. This includes new facilities for liquid glucose (180 TPD) and maltodextrin powder (50 TPD). The captive co-generation power plant capacity was expanded by 10 MW, bringing the total to 15.8 MW. The total capex outlay for the project was revised upwards to approximately ₹540 crores, with ₹401 crores spent by March 31, 2026, and the balance ₹140 crores expected in FY27.
Strategic Outlook
Management stated that the facility will progressively ramp up to optimal operating levels over the coming weeks. The company is expanding its value-added portfolio to include dextrose anhydrous, dextrose monohydrate, hydrol, and modified starches. The net debt-equity ratio improved to 1.1x from 1.9x in FY25, and the cash conversion cycle improved to 50 days from 93 days in the previous year. The company deferred providing a formal earnings outlook until the end of H1 FY27 to allow for stabilized operations.
Historical Stock Returns for Regaal Resources
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.52% | -2.66% | -15.16% | +5.34% | -41.53% | -41.53% |
How will the remaining ₹140 crores capex outlay in FY27 impact the company's free cash flow and debt levels?
What is the projected revenue contribution from the new value-added products once the facility reaches optimal capacity?
Will the improved cash conversion cycle and debt-equity ratio support further dividend increases in future fiscal years?































